Incorrect vial labeling was found – the phrases “concentrate for solution for infusion”, “for intravenous use”, “dilute before use” were in Slovak and Czech, which may hinder correct administration and a risk to health cannot be excluded. Potential effects: serious administration errors, lack of efficacy or treatment complications.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use product from batch 1004497. Healthcare institutions and pharmacies should immediately withdraw this batch from use and return it to the wholesaler or marketing authorisation holder; in case...
The Soliris batch 1004497 was withdrawn from the market throughout the country and its placing on the market was prohibited; the decision was given immediate enforceability.
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related